Monitor the stock price trajectory over the next 180 days for any closing above $1.00. A reverse stock split proposal would likely require a shareholder vote and could appear in a proxy filing. Failure to regain compliance by April 26, 2027 would trigger delisting proceedings, severely reducing liquidity and institutional ownership.
Price Chart
Executive Summary
Neumora Therapeutics received a Nasdaq deficiency notice for failing to maintain the $1.00 minimum bid price on the Global Select Market. The company has 180 days, until April 26, 2027, to regain compliance by closing at or above $1.00 for ten consecutive business days. Management is considering a reverse stock split but cannot assure compliance, creating material delisting risk for this $74M market cap biotech.
Key Facts
- Received Nasdaq written notice on October 26, 2026 for non-compliance with minimum bid price rule 5450(a)(1)
- 180-day compliance period ends April 26, 2027
- To regain compliance, closing bid price must be at least $1.00 for ten consecutive business days
- If not compliant by April 26, 2027, may apply for transfer to Nasdaq Capital Market with additional cure period
- Company considering options including a reverse stock split
- Market capitalization is $74M with 16.4% normal daily volatility
Financial Impact
Delisting risk for a $74M market cap company; reverse stock split would be required to regain compliance
Risk Factors
- Actual delisting if bid price remains below $1.00 after compliance period and any extensions
- Reverse stock split may not be approved or may not sustainably lift the stock price
- Delisting would severely reduce institutional ownership and liquidity
- Company may fail to meet other Nasdaq listing standards for transfer to Capital Market
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-441634 |
| Document: 0001193125-26-441634-index-headers.html | 0001193125-26-441634 |
| Document: 0001193125-26-441634-index.html | 0001193125-26-441634 |
| Document: 0001193125-26-441634.txt | 0001193125-26-441634 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 30, 2026 2d ago | 8-K | $0.4068 | awaiting T+1 | awaiting T+1 | $0.3670 (+9.78%) |
Sep 22, 2026 5w ago | Institutional Cluster | $0.7785 $0.7313 | ▼ −6.06% | ▼ −5.34% | $0.3670 (−52.86%) |
Aug 20, 2026 10w ago | 144 | $1.63 $1.53 | ▲ +6.44% | ▲ +6.15% | $0.3670 (+77.48%) |
Aug 17, 2026 10w ago | 144 | $1.64 $1.64 | · 0.00% | ▲ +0.21% | $0.3670 (+77.62%) |
Aug 14, 2026 11w ago | 8-K | No price | awaiting T+1 | awaiting T+1 | No price |
Aug 14, 2026 11w ago | Press Release | $1.60 $1.52 | ▼ −5.00% | ▼ −4.53% | $0.3670 (−77.06%) |
Jul 27, 2026 13w ago | 8-K | $1.66 $1.68 | ▲ +1.20% | ▲ +0.97% | $0.3670 (−77.89%) |
Jul 27, 2026 13w ago | Press Release | $1.66 $1.68 | ▲ +1.20% | ▲ +0.97% | $0.3670 (−77.89%) |
Jun 15, 2026 19w ago | 8-K | $0.9145 $1.56 | ▼ −70.58% | ▼ −71.18% | $0.3670 (+59.87%) |
Apr 17, 2026 28w ago | DEFA14A | $2.19 $2.32 | ▲ +5.94% | ▲ +6.59% | $0.3670 (−83.24%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers